Announcements

    Drinks

      Scope publishes analytical report on Axpo Holding AG
      THURSDAY, 22/12/2022 - Scope Ratings GmbH
      Download PDF

      Scope publishes analytical report on Axpo Holding AG

      Scope has released the analytical report associated to the recent rating assignment of an S-1 short-term debt rating to Axpo Holding AG and its financing subsidiary Axpo International on 8 December 2022.

      Following the recent rating assignment of an S-1 short-term debt rating to Axpo Holding AG and its financing subsidiary Axpo International SA on 8 December 2022 (click here for the corresponding rating action release), Scope has released the associated analytical report.

      This note does not constitute a rating action, nor does it indicate the likelihood of a credit rating action in the short term. The latest information on the credit ratings in this monitoring note along with the associated rating history can be found here.

      Download the full report here.


       

      Related news

      Show all
      Scope publishes analytical report on ITK Holding Zrt.

      9/10/2025 Monitoring note

      Scope publishes analytical report on ITK Holding Zrt.

      European electricity: Germany, Netherlands, Belgium grapple with EUR 200bn-plus grid capex challenge

      7/10/2025 Research

      European electricity: Germany, Netherlands, Belgium grapple ...

      Scope downgrades Hungarian biofuels producer Pannonia Bio to B+; revises Outlook to Negative

      6/10/2025 Rating announcement

      Scope downgrades Hungarian biofuels producer Pannonia Bio to ...

      Scope affirms B-/Negative issuer rating on MetMax

      29/9/2025 Rating announcement

      Scope affirms B-/Negative issuer rating on MetMax

      Scope affirms BBB-/Negative rating of Norwegian Property

      29/9/2025 Rating announcement

      Scope affirms BBB-/Negative rating of Norwegian Property

      US pharma tariffs redirect investment, spreading credit risk unevenly across sector’s value chain

      29/9/2025 Research

      US pharma tariffs redirect investment, spreading credit risk ...